The healthcare startup, whose mission is to make prescription drugs easily accessible — by making them more affordable in emerging markets, secured the funding from undisclosed investors. Although there’s no information about the investors as of yet, this document from the company’s US Securities and Exchanges Commission (SEC) filing confirms the figures.